5-Acetyl-3-bromo-6-[(E)-2-(dimethylamino)ethenyl]-2(1H)-pyridinone
- $599 - $858
- Product name: 5-Acetyl-3-bromo-6-[(E)-2-(dimethylamino)ethenyl]-2(1H)-pyridinone
- CAS: 147293-24-1
- MF: C11H13BrN2O2
- MW: 285.14
- EINECS:
- MDL Number:MFCD13193068
- Synonyms:5-Acetyl-3-bromo-6-[(E)-2-(dimethylamino)ethenyl]-2(1H)-pyridinone;5-acetyl-3-bromo-6-<2-(dimethylamino)ethenyl>pyridin-2(1H)-one;2(1H)-Pyridinone, 5-acetyl-3-bromo-6-[2-(dimethylamino)ethenyl]-
3 prices
Selected condition:
Brand
- AK Scientific
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- ManufacturerAK Scientific
- Product number4502AD
- Product description5-Acetyl-3-bromo-6-[(E)-2-(dimethylamino)ethenyl]-2(1H)-pyridinone
- Packaging500mg
- Price$858
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11252539
- Product description(E)-5-Acetyl-3-bromo-6-(2-(dimethylamino)vinyl)pyridin-2(1H)-one 95+%
- Packaging1g
- Price$630
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number048644
- Product description5-Acetyl-3-bromo-6-[(E)-2-(dimethylamino)ethenyl]-2(1H)-pyridinone >95%
- Packaging500mg
- Price$599
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 4502AD | 5-Acetyl-3-bromo-6-[(E)-2-(dimethylamino)ethenyl]-2(1H)-pyridinone | 500mg | $858 | 2021-12-16 | Buy |
Crysdot | CD11252539 | (E)-5-Acetyl-3-bromo-6-(2-(dimethylamino)vinyl)pyridin-2(1H)-one 95+% | 1g | $630 | 2021-12-16 | Buy |
Matrix Scientific | 048644 | 5-Acetyl-3-bromo-6-[(E)-2-(dimethylamino)ethenyl]-2(1H)-pyridinone >95% | 500mg | $599 | 2021-12-16 | Buy |
Properties
Melting point :236-238(dec)°
Boiling point :345.2±42.0 °C(Predicted)
Density :1.542±0.06 g/cm3(Predicted)
pka :6.40±0.10(Predicted)
Boiling point :345.2±42.0 °C(Predicted)
Density :1.542±0.06 g/cm3(Predicted)
pka :6.40±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|